Medication
Use During Pregnancy and Breastfeeding |
Articles, Chapters, and MMWRs
The following
are articles and publications that include CDC authors and highlight some
of CDC’s work in the area of medication use during pregnancy.
Lagoy CT,
Joshi N, Cragan JD, Rasmussen SA. Medication Use During Pregnancy and
Lactation: An Urgent Call for Public Health Action. J Women’s Health. 2005
Mar;14(2):103-108.
Abstract
Werler MM,
Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter
medications during pregnancy. Am J Obstet Gynecol. 2005;193(3 Pt 1):771-7.
Abstract
Honein MA,
Moore CA, Erickson JD. Can we ensure the safe use of known human teratogens?
Introduction of generic isotretinoin in the US as an example. Drug Saf.
2004;27(14):1069-80.
Abstract
Evaluation of
an association between loratadine and hypospadias--United States,
1997-2001. MMWR. 2004;53(10):219-21.Full
text
Abe K, Honein
MA, Moore CA. Maternal febrile illnesses, medication use, and the risk of
congenital renal anomalies. Birth Defects Res Part A Clin Mol Teratol.
2003;67(11):911-8.
Abstract
Daniel KL,
Honein MA, Moore CA. Sharing prescription medication among teenage girls:
potential danger to unplanned/undiagnosed pregnancies.
Pediatrics. 2003 May;111(5 Part 2):1167-70.
Abstract
Williams J,
Lyss S, and Cragan J. Your pregnant or lactating patient has been exposed
to anthrax: now what? Contemporary OB/GYN. 2003:84-98. No Abstract
Available
Honein MA,
Moore CA, Lyon Daniel K, Erickson JD. Problems with informing women
adequately about teratogen risk: some barriers to preventing exposures to
known teratogens. Teratology. 2002 May;65(5):202-4. No Abstract
Available
Olney RS, Moore CA. Translating research
findings into public health action and policy. In: Wyszynski DF, editor.
Cleft lip and palate. From origin to treatment. New York: Oxford University
Press;2002:488-94. No Abstract Available
Honein MA,
Paulozzi LJ, Erickson JD Continued occurrence of Accutane®-exposed
pregnancies Teratology. 2001 Sep;64(3):142-7
Abstract
Yoon PW,
Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P,
Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. The National
Birth Defects Prevention Study. Public Health Rep. 2001;116 Suppl 1:32-40.
Abstract
Honein MA,
Paulozzi LJ, Cragan JD, Correa A. Evaluation of selected characteristics of
pregnancy drug registries. Teratology. 1999;60(6):356-64.
Abstract
Accutane®-exposed
pregnancies--California, 1999. MMWR. 2000;49(2):28-31.
Full text
Isotretinoin--A
newly recognized human teratogen. MMWR. 1984;33(13):171-3.
Full text
Guidelines and Recommendations
The following
guidelines and recommendations were drafted by scientists from CDC and
other agencies.
Managing Asthma During Pregnancy: Recommendations for Pharmacologic
Treatment--Update 2004
Full
Text
These NIH recommendations, updated during 2004, provide guidance on
pharmacological treatment for pregnant women with asthma.
Updated
Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant
Women After Exposure to Bacillus anthracis
Full Text
These recommendations, published in the Morbidity and Mortality Weekly
Report, are used to provide guidance for physicians in choosing the best
antibiotic for their patient.
Smallpox
Vaccination Information for Women Who are Pregnant or Breastfeeding
Full Text
U.S. Public
Health Service Task Force Recommendations for Use--of Antiretroviral Drugs
in Pregnant HIV-1--Infected Women for Maternal Health and Interventions To
Reduce Perinatal HIV-1 Transmission in the United States
Full Text
Date: October 29, 2004
Content source: National Center on Birth Defects and Developmental
Disabilities
|